NEOSTEM, INC.

Basic Information

420 LEXINGTON AVE SUITE 350
NEW YORK, NY, -

Company Profile

n/a

Additional Details

Field Value
DUNS: 42403451
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Development of Adult Pluripotent Very Small Embryonic Like (VSEL) Stem Cells to T

    Amount: $147,765.00

    DESCRIPTION (provided by applicant): Scleroderma is an autoimmune, connective tissue disorder which causes fibrosis of the skin and internal organs. In the skin, there is overproduction of extracellul ...

    SBIR Phase I 2013 Department of Health and Human Services
  2. Repair of Bone Defects with Human Autologous Pluripotent Very Small Embryonic lik

    Amount: $1,221,854.00

    DESCRIPTION (provided by applicant): Bone loss due to fractures and disease is a serious medical condition in the US affecting millions of Americans. It is particularly a problem with oral craniofaci ...

    SBIR Phase II 2012 Department of Health and Human Services
  3. Development of Human, Autologous, Pluripotent Very Small Embryonic Like (VSELs) s

    Amount: $595,252.00

    DESCRIPTION (provided by applicant): In the event of a nuclear accident or terrorist bomb, large numbers of casualties will have been exposed to acute high-dose radiation. Those exposed will have co ...

    SBIR Phase I 2012 Department of Health and Human Services
  4. Repair of boney defects by human stem cells

    Amount: $108,746.00

    DESCRIPTION (provided by applicant): In alignment with Healthy People 2010 (Arthritis/Osteoporosis) and research objectives established by the NIAMS, the overall goal of this study is to prevent illne ...

    SBIR Phase I 2009 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government